#United States #New York #The Gross Law Firm #Savara Inc #SVRA

Shareholders of Savara Inc. - Important Class Action Alert

On October 9, 2025, The Gross Law Firm issued a crucial notice for shareholders of Savara Inc., listed on NASDAQ under the ticker SVRA. This announcement is especially significant for those who acquired shares during the defined class period from March 4, 2024, to May 23, 2025.

The legal notice emphasizes the importance of registering for participation in the pending class action lawsuit. The firm's notice addresses shareholders who may have faced financial losses due to the alleged misleading statements made by the company regarding its developmental drug, MOLBREEVI. This drug aimed to treat pulmonary alveolar proteinosis, but the complaints assert that Savara failed to disclose vital information regarding its chemistry and manufacturing controls. As a result, the FDA's approval for MOLBREEVI in its current form appears unlikely.

The implications are serious: shareholders are being informed that these failures might lead the company necessitating additional capital, which can further hurt the stock's valuation. The allegations state that, as a result of these misleading public statements, investors have been left in a precarious position.

To ensure that shareholders are appropriately informed, The Gross Law Firm encourages investors to contact them regarding possible lead plaintiff appointments. It's important to note that becoming a lead plaintiff is not a requirement for participating in any recovery linked to the case. Interested shareholders are urged to visit The Gross Law Firm's website to register their information.

The firm has set a deadline for registration – November 7, 2025. Shareholders must act promptly to secure their participation in this case. Once registered, participants will be enrolled in a portfolio monitoring program, which will keep them updated throughout the litigation process concerning the case's progress.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its commitment to protecting investors’ rights against deceitful and fraudulent business practices. The law firm aims to hold corporations accountable for statements that lead to artificial inflation of stock prices, ensuring that serious regulatory breaches are addressed.

For investors who have experienced losses as a result of the misleading activities of Savara Inc., this class action presents an opportunity to seek recovery. If you are a shareholder or have inquiries regarding the allegations, reach out to The Gross Law Firm at 15 West 38th Street, 12th Floor, New York, NY 10018, via email at [email protected], or by phone at (646) 453-8903.

In legal matters such as these, timely action can be crucial. Thus, shareholders of Savara Inc. are strongly encouraged to register as soon as possible to ensure their interests are represented in this significant pending class action lawsuit.